Celltrion Inc (068270) – Company Profile and SWOT Analysis

Celltrion Inc (068270) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on the research, development, and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis, and psoriasis. Its pipeline portfolio spans monoclonal antibody biosimilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer, and seasonal influenza. Celltrion develops drugs by using its bioengineering and mammalian cell-culture technology. It also carries out contract manufacturing of biosimilars. The company has an operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon, South Korea

Scope

• Detailed information on Celltrion Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Celltrion Inc in the form of a SWOT analysis

• An in-depth view of the business model of Celltrion Inc including a breakdown and examination of key business segments

• News about Celltrion Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Celltrion Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Celltrion Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Celltrion Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Biocon Biologics Ltd

Samsung Bioepis Co Ltd

JW Pharmaceutical Corp

Sandoz Group AG

Amgen Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Celltrion Inc - Key Facts

Celltrion Inc - Key Employees

Celltrion Inc - Key Employee Biographies

Celltrion Inc - Major Products and Services

Celltrion Inc - History

Celltrion Inc - Company Statement

Celltrion Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Celltrion Inc - Business Description

Business Segment: Biopharmaceutical Medicines

Overview

Performance

Business Segment: Chemical Medicines

Overview

Performance

Business Segment: Other

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Central and South America

Performance

Geographical Segment: Domestic Market

Performance

Geographical Segment: Europe

Performance

Geographical Segment: North America

Performance

R&D Overview

Celltrion Inc - Corporate Strategy

Celltrion Inc - SWOT Analysis

SWOT Analysis - Overview

Celltrion Inc - Strengths

Celltrion Inc - Weaknesses

Celltrion Inc - Opportunities

Celltrion Inc - Threats

Celltrion Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Celltrion Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 15, 2026: Celltrion Launches Two New Anticancer Drugs in Vietnam Accelerating Targeting of Global Pharma Emerging Markets in Asia and Latin America

May 27, 2026: Celltrion Science & Innovation Day 2026' Held Analysts and Institutional Investors Focus on 'New Drug Valuations

May 26, 2026: Celltrion Introduces AI to Three Major Areas: New Drug Development, Manufacturing, and Administration; Establishes Differentiated Systems for Each Task to Expand Global Competitiveness

May 13, 2026: Celltrion Included in Dow Jones Sustainability World Index for Two Consecutive Years Proving Responsible Management Through 'Global Standard' ESG Evaluation

May 06, 2026: Celltrion Records

1.145 Trillion Won in Revenue and

321.9 Billion Won in Operating Profit in the First Quarter

Apr 23, 2026: Celltrion Enters Patient Dosage for All 3 New ADC Drugs Clinical Trials on Track, Accelerating Leap to Global New Drug Company

Apr 16, 2026: Celltrion Sees Widespread Prescriptions for Key Product Lines in Europe Expectations for Success of High-Profit New Products Growing Driven by Field-Oriented Direct Sales Performance

Apr 15, 2026: Celltrion Selected Only in Korea for Top 1% in Biotechnology Sector of S&P ESG Evaluation Recognized for Practicing Top-Tier Global ESG Management

Mar 24, 2026: Celltrion Announces KRW

1.2Tn Expansion of New DS Production Facilities in Songdo; Adds 180,000L of DS capacity, bringing total capacity to 570,000L

Mar 18, 2026: Celltrion Healthcare Japan and CMIC Group Sign MOU to Expand Biosimilars in Japan

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Celltrion Inc, Key Facts

Celltrion Inc, Key Employees

Celltrion Inc, Key Employee Biographies

Celltrion Inc, Major Products and Services

Celltrion Inc, History

Celltrion Inc, Other Locations

Celltrion Inc, Subsidiaries

Celltrion Inc, Key Competitors

Celltrion Inc, Ratios based on current share price

Celltrion Inc, Annual Ratios

Celltrion Inc, Annual Ratios (Cont…1)

Celltrion Inc, Annual Ratios (Cont…2)

Celltrion Inc, Interim Ratios

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Celltrion Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Celltrion Inc, Performance Chart (2020 – 2024)

Celltrion Inc, Ratio Charts

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports